References
- 1. Bănescu C, Iancu M, Trifa AP, Dobreanu M, Moldovan VG, Duicu C et al. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population. Tumour Biol. 2016;37(7):9357-66. DOI: 10.1007/s13277-016-4815-610.1007/s13277-016-4815-626779634
- 2. Arber DA. Acute myeloid leukemia, in His Eric D (Eds), Hematopathology, 3nd Ed, Elsevier Philadelphia, 2019, 429-466. DOI: 10.1016/B978-0-323-47913-4.00030-6.10.1016/B978-0-323-47913-4.00030-6
- 3. Bullinger L, Döhner K, Döhner H. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. J Clin Oncol. 2017;35(9):934-46. DOI: 10.1200/JCO.2016.71.220810.1200/JCO.2016.71.220828297624
- 4. Bănescu C, Iancu M, Trifa AP, Cândea M, Benedek Lazar E, Moldovan VG et al. From Six Gene Polymorphisms of the Antioxidant System, Only GPX Pro198Leu and GSTP1 Ile105Val Modulate the Risk of Acute Myeloid Leukemia. Oxid Med Cell Longev. 2016;2016:2536705. DOI: 10.1155/2016/253670510.1155/2016/2536705470732526823947
- 5. Antohe I, Dăscălescu A, Dănăilă C, Zlei M, Ivanov I, Sireteanu A, et al. FLT-3 ITD Positive Acute Basophilic Leukemia with Rare Complex Karyotype Presenting with Acute Respiratory Failure: Case Report. Rev Romana Med Lab. 2018;26(1):87-94. DOI: 10.1515/rrlm-2017-003610.1515/rrlm-2017-0036
- 6. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-405. DOI: 10.1182/blood-2016-03-64354410.1182/blood-2016-03-64354427069254
- 7. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood.2017;129(4):424-47. DOI: 10.1182/blood-2016-08-73319610.1182/blood-2016-08-733196529196527895058
- 8. Crauciuc GA, Tripon F, Bogliş A, Făgărăşan A, Bănescu C. Multiplex ligation dependent probe amplification - A useful, fast and cost-effective method for identification of small supernumerary marker chromosome in children with developmental delay and congenital heart defect. Rev Romana Med Lab. 2018;26(4):461-70. DOI: 10.2478/rrlm-2018-003210.2478/rrlm-2018-0032
- 9. Bogliş A, Tripon F, Bănescu C. The utility of molecular genetic techniques in craniosynostosis cases associated with intellectual disability. Rev Romana Med Lab. 2018;26(4):471-7. DOI: 10.2478/rrlm-2018-003310.2478/rrlm-2018-0033
- 10. Vázquez-Reyes A, Bobadilla-Morales L, Barba-Barba C, Macías-Salcedo G, Serafín-Saucedo G, Velázquez-Rivera ME et al. Aneuploidy identification in pre-B acute lymphoblastic leukemia patients at diagnosis by Multiplex Ligation-dependent Probe Amplification (MLPA). Leuk Res. 2017;59:117-23. DOI: 10.1016/j.leukres.2017.05.02210.1016/j.leukres.2017.05.02228624713
- 11. Oltean A, Chincesan MI, Marginean O, Horvath E. Myelodysplastic syndrome with myelofibrosis in a 12-year-old patient – A case report. Rev Romana Med Lab. 2018;26(1):95-103. DOI: 10.1515/rrlm-2017-003410.1515/rrlm-2017-0034
- 12. Moreno I, Martín G, Bolufer P, Barragán E, Rueda E, Román J et al. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Haematologica. 2003;88(1):19-24.
- 13. Brewin JN, Horne GA, Bisling KE, Stewart HJ, Chevassut TJ. Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia. Leuk Lymphoma. 2013;54(6):1336-9. DOI: 10.3109/10428194.2012.73698610.3109/10428194.2012.73698623035745
- 14. Azari-Yam A, Bagheri SD, Tavakkoly-Bazzaz J, Sarhaddi AB, Rejali L, Alimoghaddam K et al. NPM1 Mutation Detection in Acute Myeloid Leukemia: A Method Comparison Study. Genet Test Mol Biomarkers. 2016;20(2):63-6. DOI: 10.1089/gtmb.2015.018410.1089/gtmb.2015.018426666953
- 15. Huang Q, Chen W, Gaal KK, Slovak ML, Stein A, Weiss LM. A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics. Br J Haematol. 2008;142(3):489-92. DOI: 10.1111/j.1365-2141.2008.07205.x10.1111/j.1365-2141.2008.07205.x18477048
- 16. Negura L, Negura A. Sanger sequencing of MMR genes in a one-plate system. Rev Romana Med Lab. 2018;26(2):153-63. DOI: 10.2478/rrlm-2018-000810.2478/rrlm-2018-0008
- 17. Mevatee P, Tantiworawit A, Traisathit P, Puaninta C, Mevatee U, Angsuchawan S et al. FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand. Asian Pac J Cancer Prev. 2017;18(11):3031-9. doi:10.22034/APJCP.2017.18.11.3031.
- 18. Loghavi S, Zuo Z, Ravandi F, Kantarjian HM, Bueso-Ramos C, Zhang L et al. Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations. J Hematol Oncol. 2014;7:74. DOI: 10.1186/s13045-014-0074-410.1186/s13045-014-0074-4419732625281355
- 19. Im AP, Sehgal AR, Carroll MP, Smith BD, Tefferi A, Johnson DE et al. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia. 2014 ;28(9):1774-83. DOI: 10.1038/leu.2014.12410.1038/leu.2014.124423409324699305
- 20. Cagnetta A, Adamia S, Acharya C, Patrone F, Miglino M, Nencioni A et al. Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics. Leuk Res. 2014, 38(6):649–59. DOI: 10.1016/j.leukres.2014.03.00610.1016/j.leukres.2014.03.00624726781
- 21. Coriu D, Jardan D, Jardan C, Tălmaci R, Dragomir M, Coliţă A. A new assay to identify recurrent mutations in acute myeloid leukemia using next-generation sequencing. Rev Romana Med Lab. 2014;22(1):93-9. DOI: 10.2478/rrlm-2014-000310.2478/rrlm-2014-0003
- 22. Ahn JY, Seo K, Weinberg O, Boyd SD, Arber DA. A comparison of two methods for screening CEBPA mutations in patients with acute myeloid leukemia. J Mol Diagn. 2009;11(4):319-23. DOI: 10.2353/jmoldx.2009.08012110.2353/jmoldx.2009.080121271070819525338